CompaniesSecond Genome

Second Genome

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

9

By Phase

PHASE2: 1

By Status

TERMINATED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2018

2019

2020

Today

Hover over trial bars to see details

Recent Trials

NCT03676231Lead Sponsor

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

PHASE2Terminated

Started: Jan 18, 2019 · Completed: May 1, 2019

Funding History (1)

D

Aug 9, 2011